Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Protective effect of cholecalciferol against cobalt‑induced neurotoxicity in rats: ZO‑1/iFABP, ChAT/AchE and antioxidant pathways as potential therapeutic targets
Cobalt (Co) toxicity has been reported to produce central nervous system and gastrointestinal abnormalities. This study assessed the therapeutic effect of cholecalciferol (Cho) supplementation against damages caused by sub-acute (14-day) cobalt chloride (CoCl2) exposure in the brain and intestines....
Saved in:
| Format: | Article |
|---|---|
| Published: |
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000njm a2000000a 4500 | ||
|---|---|---|---|
| 001 | oai:repository.ui.edu.ng:123456789/13530 | ||
| 042 | |a dc | ||
| 720 | |a Akinrinde, A. S. |e author | ||
| 720 | |a Adeoye, B. O. |e author | ||
| 720 | |a Samuel, E. S. |e author | ||
| 720 | |a Mustapha, O. A. |e author | ||
| 260 | |c 2024 | ||
| 520 | |a Cobalt (Co) toxicity has been reported to produce central nervous system and gastrointestinal abnormalities. This study assessed the therapeutic effect of cholecalciferol (Cho) supplementation against damages caused by sub-acute (14-day) cobalt chloride (CoCl2) exposure in the brain and intestines. Thirty-five male Wistar rats were divided equally into five groups: Group I (control) received no treatment; Group II received oral CoCl2 (100 mg/kg) only; Groups III, IV, and V received 1000, 3000 and 6000 IU/kg of cholecalciferol, respectively by oral gavage, and concurrently with CoCl2. Cobalt-treated rats showed neuronal vacuolation and presence of pyknotic nuclei in the cerebral cortex and hippocampus, depletion of Purkinje cells in the cerebellum, as well as inflammation and congestion in the intestinal mucosa. Cobalt also increased brain and intestinal hydrogen peroxide (H2O2) and malondialdehyde (MDA) concentrations, while simultaneously reducing glutathione (GSH) content, superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities. Further, CoCl2 induced increases in brain acetylcholinesterase (AchE) activity and serum zonulin (ZO-1) levels. Conversely, Cho administration suppressed CoCl2-induced damages in the brain and intestines by reducing lipid peroxidation and increasing the activities of antioxidant enzymes. Remarkably, Cho produced stimulation of brain choline acetyltransferase (ChAT) and suppression of AchE activity, along with dose-dependent reduction in serum levels of ZO-1, intestinal fatty acid-binding protein (iFABP) and nitric oxide. In conclusion, the protective role of cholecalciferol against cobalt-induced toxicity occurred via modulation of cholinergic, intestinal permeability and antioxidant pathways. The results may prove significant in the context of the role of gut-brain connections in neuroprotection. | ||
| 024 | 8 | |a 1559-0720 | |
| 024 | 8 | |a ui_art_akinrinde_protective_2024 | |
| 024 | 8 | |a Biological Trace Element Research | |
| 024 | 8 | |a https://repository.ui.edu.ng/handle/123456789/13530 | |
| 653 | |a Cobalt chloride | ||
| 653 | |a Brain | ||
| 653 | |a Intestines | ||
| 653 | |a Cholinergic System | ||
| 653 | |a Zonulin | ||
| 653 | |a Intestinal Fatty Acid-Binding Protein | ||
| 245 | 0 | 0 | |a Protective effect of cholecalciferol against cobalt‑induced neurotoxicity in rats: ZO‑1/iFABP, ChAT/AchE and antioxidant pathways as potential therapeutic targets |